Prediction of HLA-DQ8 β cell peptidome using a computational program and its relationship to autoreactive T cells

被引:25
作者
Chang, Kuan Y. [1 ,2 ]
Unanue, Emil R. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Computat Biol Program, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
HLA-DQ8; MHC class II molecules; T cell epitope prediction; type I diabetes mellitus; GLUTAMIC-ACID DECARBOXYLASE; NONOBESE DIABETIC MICE; DQ TRANSGENIC MICE; CLASS-II MOLECULE; BINDING PEPTIDES; IMMUNE-RESPONSE; MHC MOLECULES; NOD MICE; HLA-DR; ACETYLCHOLINE-RECEPTOR;
D O I
10.1093/intimm/dxp039
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The goal was to identify HLA-DQ8-bound beta cell epitopes important in the T cell response in autoimmune diabetes. We first identified HLA-DQ8 (DQA1*0301/DQB1*0302) beta cell epitopes using a computational approach and then related their identification to CD4 T cell responses. The computational program (TEA-DQ8) was adapted from one previously developed for identifying peptides bound to the I-A(g7) molecule and based on a library of naturally processed peptides bound to HLA-DQ8 molecules of antigen-presenting cells. We then examined experimentally the response of NOD.DQ8 mice immunized with peptides derived from the Zinc transporter 8 protein. Log-of-odds scores on peptides were experimentally validated as an indicator of peptide binding to HLA-DQ8 molecules. We also examined previously published data on diabetic autoantigens, including glutamic acid decarboxylase-65, insulin and insulinoma-associated antigen-2, all tested in NOD.DQ8 transgenic mice. In all examples, many peptides identified with a favorable binding motif generated an autoimmune T cell response, but importantly many did not. Moreover, some peptides with weak-binding motifs were immunogenic. These results indicate the benefits and limitations in predicting autoimmune T cell responses strictly from MHC-binding data. TEA-DQ8 performed significantly better than other prediction programs.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 48 条
[1]   NOD background genes influence T cell responses to GAD 65 in HLA-DQ8 transgenic mice [J].
Abraham, RS ;
Wilson, SB ;
de Souza, NF ;
Strominger, JL ;
Munn, SR ;
David, CS .
HUMAN IMMUNOLOGY, 1999, 60 (07) :583-590
[2]   THE 1ST EXTERNAL DOMAIN OF THE NONOBESE DIABETIC MOUSE CLASS-II I-A BETA-CHAIN IS UNIQUE [J].
ACHAORBEA, H ;
MCDEVITT, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (08) :2435-2439
[3]   A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin [J].
Alleva, DG ;
Crowe, PD ;
Jin, LP ;
Kwok, WW ;
Ling, N ;
Gottschalk, M ;
Conlon, PJ ;
Gottlieb, PA ;
Putnam, AL ;
Gaur, A .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (02) :173-180
[4]   MHCBN: a comprehensive database of MHC binding and non-binding peptides [J].
Bhasin, M ;
Singh, H ;
Raghava, GPS .
BIOINFORMATICS, 2003, 19 (05) :665-666
[5]   SVM based method for predicting HLA-DRB1*0401 binding peptides in an antigen sequence [J].
Bhasin, M ;
Raghava, GPS .
BIOINFORMATICS, 2004, 20 (03) :421-423
[6]   JenPep: a database of quantitative functional peptide data for immunology [J].
Blythe, MJ ;
Doytchinova, IA ;
Flower, DR .
BIOINFORMATICS, 2002, 18 (03) :434-439
[7]   Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, nonobese diabetic mice and HLA-DQ transgenic mice [J].
Boyton, RJ ;
Lohmann, T ;
Londei, M ;
Kalbacher, H ;
Halder, T ;
Frater, AJ ;
Douek, DC ;
Leslie, RDG ;
Flavell, RA ;
Altmann, DM .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (12) :1765-1776
[8]   MHCPEP, a database of MHC-binding peptides: update 1997 [J].
Brusic, V ;
Rudy, G ;
Harrison, LC .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :368-371
[9]   Predicting peptides bound to I-Ag7 class II histocompatibility molecules using a novel expectation-maximization alignment algorithm [J].
Chang, Kuan Y. ;
Suri, Anish ;
Unanue, Emil R. .
PROTEOMICS, 2007, 7 (03) :367-377
[10]  
Chapoval SP, 1998, J IMMUNOL, V161, P2032